Immune Checkpoint Inhibitor-Induced Polyarthritis: A Case Series
Immune checkpoint inhibitors (ICIs) have revolutionized cancer care; however, they are associated with ICI-related adverse events (ICI-AEs). Polyarthritis is a rare ICI-AE. Here we describe 2 patient cases of ICI-induced polyarthritis, induced by nivolumab/ipilimumab and sasanlimab for melanoma and...
Saved in:
| Main Authors: | Megan Smith-Uffen, Konstantinos Tselios |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2023-01-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2022.0815 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Acral vasculitis induced by Immune Checkpoint Inhibitors: a case series and literature review
by: Valérian Rivet, et al.
Published: (2025-05-01) -
Immune checkpoint inhibitor-associated diabetes mellitus: the case series report
by: Yuhong Ma, et al.
Published: (2025-07-01) -
Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single‐center case series
by: Joshua Longinow, et al.
Published: (2023-02-01) -
Hepatotoxicity induced by immune checkpoint inhibitors
by: Flaviu Muresan, et al.
Published: (2024-10-01) -
Hidradenitis suppurativa in the setting of immune checkpoint inhibitor therapy: A case series
by: Liam M. Dalton, BA, et al.
Published: (2025-05-01)